Toll Free 1-888-590-9839

  • Modern Veterinary Therapeutics, LLC announces today that the Veterinary Drugs Directorate (VDD) has approved Enrotron 50 (enrofloxacin injection – 50mg/mL) in Canada. Enrotron 50, presented in a 100mL vial, is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. “Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada which further expands our veterinary product line for small animal,” said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.